HIP125 details

HIPidHIP125
SequenceGKARGWFY
Length8
Nomenclaturevif 33-40
Sourcevif
Cell line NA
Inhibition/IC50  94.8
Unit %
TargetProtease inhibition
AssayHPLC
PropertiesView
StructureJmol
PaperPeptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
AuthorsFriedler A, Blumenzweig I, Baraz L, Steinitz M, Kotler M, Gilon C.
ReferenceJ Mol Biol. 1999 Mar 19;287(1):93-101.
Pubmed ID10074409

 CSIR-Institute of Microbial Technology, Chandigarh 160036, India